Universal Health Services (UHS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Net revenues increased 9.6% year-over-year to $4.50 billion for Q1 2026, with strong growth in both acute care and behavioral health segments.
Net income attributable to shareholders rose 10% to $349 million ($5.65 per diluted share), with adjusted EPS up 16.1% year-over-year.
EBITDA net of NCI reached $651.7 million, up from $603.9 million year-over-year.
Announced definitive agreement to acquire Talkspace, a leading virtual behavioral health platform, for $835 million, expected to close in Q3 2026 and be accretive to earnings within 12 months post-closing.
Maintained steady operating performance and cash flow despite challenging seasonal volume trends.
Financial highlights
Operating income rose to $503 million from $455 million year-over-year.
Cash flow from operations was $402 million, up from $360 million year-over-year.
Capital expenditures totaled $217 million in Q1 2026.
Repurchased 675,000 shares for $127 million; $1.3 billion buyback authorization remains.
Debt/total capitalization improved to 38.7% from 40.7% year-over-year.
Outlook and guidance
Reiterated full-year 2026 financial and operating guidance set in February.
Expects earnings ramp through the year to achieve core 5% growth target, with volume and pricing more balanced as seasonal impacts subside.
Guidance includes $75 million pre-tax impact from health insurance exchange (HIX) declines, expected to steepen as the year progresses.
Anticipate annual net benefit from Medicaid supplemental payment programs to decline by $432–$480 million by 2032 due to legislative changes.
Management highlighted risks from changes in Medicaid and Medicare funding, new legislation affecting Medicaid eligibility, and interest rate volatility.
Latest events from Universal Health Services
- Strong 2025 results and 2026 growth outlook, with ongoing investment and managed regulatory risks.UHS
Q4 20259 Jul 2026 - Q2 2025 net income up 22% with strong revenue, margin gains, and higher EPS guidance amid Medicaid risks.UHS
Q2 20258 Jul 2026 - Q1 2025 net income rose 21% on 6.7% revenue growth, with strong segment performance.UHS
Q1 20258 Jul 2026 - Strong 2024 performance, margin recovery, and behavioral growth drive optimism despite policy headwinds.UHS
KeyBanc Annual Healthcare Forum 20258 Jul 2026 - AI, outpatient growth, and capital deployment drive margin and volume strategies for 2026.UHS
Goldman Sachs 47th Annual Global Healthcare Conference 20269 Jun 2026 - Directors and auditors were approved; shareholder proposal on voting structure was rejected.UHS
AGM 202620 May 2026 - Revenue growth, operational expansion, and AI-driven efficiency shape a positive outlook.UHS
Bank of America Global Healthcare Conference 202618 May 2026 - Virtual annual meeting to vote on director, pay, auditor, and ESG-related proposals.UHS
Proxy filing9 Apr 2026 - Board recommends for director elections and compensation, against both shareholder proposals.UHS
Proxy filing9 Apr 2026